A Pharmacokinetic Study of AMG 386 in Cancer Subjects With Normal and Impaired Renal Function

NCT01331941 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

35

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Solid Tumors
Kidney Disease
Renal Impairment

Interventions

DRUG: AMG 386 + Paclitaxel
DRUG: AMG 386

Sponsor

Amgen